Lv51
908 积分 2025-06-18 加入
Maximizing therapeutic potential and safety: Exploring multi/dual-payload antibody conjugates as cancer theranostics
9小时前
待确认
An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Anti-Tumor Responses in KRAS and BRAF Mutant Colorectal Cancer
9小时前
待确认
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune Activation
10小时前
待确认
Dual-payload ADCs move into first oncology clinical trials
11天前
已完结
Patient Values and Preferences in Chronic Urticaria Treatment
12天前
已完结
Successful Treatment of Alopecia Areata With One JAK Inhibitor After Failure of Other JAK Inhibitors
12天前
已完结
MRGPRX2 Gain-of-Function Mutation Drives Enhanced Mast Cell Reactivity in Chronic Spontaneous Urticaria
13天前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities
1个月前
已完结
皖公网安备34019202002308
